載入...
Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies
CD16a (FcγRIIIa) mediates the antibody dependent cellular cytotoxicity (ADCC) and is important for anti-tumor activities of many therapeutic antibodies. Bispecific antibody targeting natural killer (NK) cells has been studied for cancer therapy. In this work, anti-CD16a single-domain antibodies were...
Na minha lista:
| 發表在: | Cancer Biol Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7012161/ https://ncbi.nlm.nih.gov/pubmed/31564196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1665953 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|